UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001205 |
|---|---|
| Receipt number | R000001470 |
| Scientific Title | Phase II study of weekly paclitaxel (wP) followed by doxorubicin plus paclitaxel (AP) as neo-adjuvant chemotherapy for triple negative Breast Cancer (WePAP) |
| Date of disclosure of the study information | 2008/06/21 |
| Last modified on | 2018/12/18 19:53:20 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/06/20 20:12:44 | ||
| 2 | Update | 2011/12/20 18:49:21 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2013/12/21 08:08:36 | Email |
|
| 4 | Update | 2015/02/16 19:07:10 | Recruitment status Last follow-up date |
|
| 5 | Update | 2017/11/30 18:03:27 | UMIN ID1 |
|
| 6 | Update | 2018/12/18 19:53:20 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
